An Open, Randomised, Parallel-Group, Multicentre Trial to Compare the Efficacy of a Stratified Treatment Regimen for Acute Migraine Attacks, in whichPatients Receive Therapy According to the Grade of their Migraine Disability at Baseline, Assessed by the MIDAS Questionnaire, with that of 2 Other Treatment Regimens, in which Patients Receive Standard Therapy that may be altered after 3 Attacks (Stepped Care) or within Individual Attacks (Staged Care).

Study identifier:311CIL/0081

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An Open, Randomised, Parallel-Group, Multicentre Trial to Compare the Efficacy of a Stratified Treatment Regimen for Acute Migraine Attacks, in whichPatients Receive Therapy According to the Grade of their Migraine Disability at Baseline, Assessed by the MIDAS Questionnaire, with that of 2 Other Treatment Regimens, in which Patients Receive Standard Therapy that may be altered after 3 Attacks (Stepped Care) or within Individual Attacks (Staged Care).

Medical condition

migraine

Phase

N/A

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Jan 1971
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Dec 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria